Market Insights Health Hospitals Inpatient Care

Treatment of Musculoskeletal Diseases - Spain

Spain

The Treatment of Musculoskeletal Diseases market in Spain is projected to reach a revenue of €2.20bn in 2024.
It is expected to show an annual growth rate (CAGR 2024-2029) of 1.92%, resulting in a market volume of €2.42bn by 2029.
In global comparison, in the United States is expected to generate the highest revenue, estimated at €56,370.00m in 2024.
In Spain, there is a growing trend towards incorporating alternative treatments, such as acupuncture and herbal medicine, into the treatment of musculoskeletal diseases.

Key regions: Europe, Canada, United States, Germany, India

Marché

Région

Comparaison de régions

Monnaie

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.